BAIN CAPITAL INVESTORS LLC Q4 2023 Filing

Filed February 13, 2024

Portfolio Value

$4611.8T

Holdings

4

Report Date

Q4 2023

Filing Type

13F-HR

All Holdings (4 positions)

#StockSharesValue% PortfolioType
1
CERE1EURCEREVEL THERAPEUTICS HLDNG I
65,679,781$2784.8T60.39%
2
SGRYSURGERY PARTNERS INC
49,946,972$1597.8T34.65%
3
AVAHAVEANNA HEALTHCARE HLDGS INC
81,600,880$218.7T4.74%
4
ADVADVANTAGE SOLUTIONS INC
2,890,000$10.5T0.23%